Rubicon Inks European Distribution Pacts | GenomeWeb

NEW YORK (GenomeWeb) – Rubicon Genomics today said that it has signed a series of distribution agreements covering Europe in advance of the launch of its new sequencing preparation kits.

The distribution agreements were signed with Cambridge Bioscience for the UK and Ireland; Biozym Scientific for Germany and Austria; AB Analitica for Italy; Sopachem for the Benelux countries; Nordic Biolabs for Denmark and Sweden; Immuno Diagnostic for Finland; and YBUX for Romania, the Slovak Republic, and the Czech Republic.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Mar
09
Sponsored by
Bio-Rad

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.